Cervical cancer screening intervals, 2006 to 2009: Moving beyond annual testing

JAMA Internal Medicine

Volumn 173, Issue 10, 2013, Pages 922-924

  Berkowitz, Zahava ^a   Saraiya, Mona ^a   Sawaya, George F ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER SCREENING; PAPANICOLAOU TEST; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; UTERINE CERVIX CANCER; WART VIRUS;

ADULT; AGE FACTORS; AMBULATORY CARE; EARLY DETECTION OF CANCER; FEMALE; HEALTH CARE SURVEYS; HUMANS; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; TIME FACTORS; UNITED STATES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84878515918     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2013.368     Document Type: Article

References (9)

1. Saslow D, Runowicz CD, Solomon D, et al American Cancer Society. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin. 2002;52(6):342-362. (Pubitemid 35446606)
2. Saraiya M, Berkowitz Z, Yabroff KR, Wideroff L, Kobrin S, Benard V. Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending? Arch Intern Med. 2010;170(11):977-985.
3. Berkowitz Z, Saraiya M, Benard VK, Yabroff KR. Common abnormal results of Pap and human papillomavirus contesting. Obstet Gynecol. 2010;116(6):1332-1340.
4. Centers for Disease Control and Prevention. About the ambulatory health care surveys: NAMCS/NHAMCS. 2009. http://www.cdc.gov/nchs/ahcd/about-ahcd.htm. Accessed December 12, 2012.
5. Katki HA, Kinney W, Fetterman B, et al. Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice. Lancet Oncol. 2011;12(7):663-672.
6. Peabody JW, Luck J, Glassman P, Dresselhaus TR, Lee M. Comparison of vignettes, standardized patients, and chart abstraction: a prospective validation study of 3 methods for measuring quality. JAMA. 2000;283(13):1715- 1722. (Pubitemid 30196212)
7. Saslow D, Solomon D, Lawson HW; American Cancer Society; American Society for Colposcopy and Cervical Pathology; American Society for Clinical Pathology. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer. Am J Clin Pathol. 2012;137(4):516-542.
8. Committee on Practice Bulletins-Gynecology. ACOG Practice Bulletin Number 131: screening for cervical cancer. Obstet Gynecol. 2012;120(5):1222-1238.
9. US Preventive Services Task Force. Screening for cervical cancer: US Preventive Services Task Force Recommendation Statement. http://www. uspreventiveservicestaskforce.org/uspstf/uspscerv.htm. March 2012. Accessed December 12, 2012.